How mothers and obstetricians decide the delivery method for breech babies

Impact of the Practitioner's Discourse on the Mother's Decision Regarding the Mode of Delivery in Cases of Breech Presentation

Observational University Hospital, Strasbourg, France · NCT07314970

This project asks mothers who delivered a breech baby and obstetricians in the Grand-Est region to complete anonymous questionnaires to see how decisions about vaginal birth versus cesarean are made for term breech deliveries.

Quick facts

Study typeObservational
Enrollment200 (estimated)
Ages18 Years and up
SexAll
SponsorUniversity Hospital, Strasbourg, France Academic / other
Locations1 site (Strasbourg)
Trial IDNCT07314970 on ClinicalTrials.gov

What this trial studies

This is an observational questionnaire-based project conducted at university hospitals in the Grand-Est region (Besançon, Reims, Strasbourg, Nancy). It collects anonymous responses from obstetricians working in those centers and from women aged 18 or older who delivered a breech fetus at ≥37 weeks in 2024. The questionnaires aim to document clinical, personal and institutional factors that influenced the chosen mode of delivery. The goal is to describe practice variation and the reasons behind decisions, not to change care during the study.

Who should consider this trial

Good fit: Women aged 18 or older who gave birth to a breech fetus at ≥37 weeks in 2024 at one of the participating university hospitals in the Grand-Est region are eligible to participate by completing the anonymous questionnaire.

Not a fit: Minors, patients who had a planned cesarean for a prior uterine scar or due to placenta previa/obstruction, and those who delivered outside the specified hospitals or timeframe are not eligible and would not benefit from participating.

Why it matters

Potential benefit: If successful, the findings could improve counseling and shared decision-making and help reduce unnecessary cesareans for term breech births in the region.

How similar studies have performed: Large randomized trials like the Term Breech Trial previously shaped practice for breech birth, while questionnaire and survey studies of decision-making are common but have provided mixed, region-specific insights rather than definitive solutions.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

Regarding practitioners:

* Doctor with a medical degree (Junior Doctor, Clinical Assistant, Hospital Practitioner, University Professor of Obstetrics), with a primary focus on Obstetrics
* Practicing in a University Hospital in the Grand Est region (Besançon, Reims, Strasbourg, Nancy)
* Agreeing to complete the self-administered questionnaire anonymously.

Regarding patients:

* Patient of legal age (≥ 18 years)
* Having given birth in 2024 in a university hospital in the Grand-Est region (Besançon, Reims, Strasbourg, Nancy)
* Delivery of a breech fetus \> 37 weeks of gestation
* Agreeing to answer the self-administered questionnaire anonymously.

Exclusion Criteria:

Regarding practitioners:

Other primary activity than obstetrics

Regarding patients:

* Minor patient at the time of delivery
* Patient who had a cesarean section due to a uterine scar and maternal desire.
* Patients with a history of uterine scarring or the presence of obstruction previa were also excluded due to the impossibility of authorizing vaginal delivery, regardless of fetal presentation.

Where this trial is running

Strasbourg

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Breech Presentation
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.